5-Amino-1MQ works by inhibiting NNMT (nicotinamide N-methyltransferase), an enzyme that depletes cellular NAD+ and SAM
I understand that I may have to take the medication for the rest of my life, and the risks associated with stopping medication
Gastrointestinal effects: the main titration bottleneck Nausea, diarrhea, constipation, and vomiting run around 40 to 44% overall, dose-dependent in how many people report them but mild-dominant in severity: severe events stay at or below about 1.7% in any category even at the top dose. In the obesity program the by-dose rates run nausea 25/29/28%, diarrhea 19/21/23%, and vomiting 8/11/13% at 5/10/15 mg. They concentrate during escalation and ease with time on a held dose
Alleviation of Anemia Symptoms: B12 injections can help address anemia caused by B12 deficiency, improving symptoms like weakness and pallor
Further interpretation of the data suggests that BPC 157 might modulate focal adhesion kinase and paxillin-associated pathways involved in F-actin formation
